Products

Sandoo magnum est Ketorolac Trometamolum, Hydrochloridum Olopatadinum, Vancomycin hydrochloridum artifices et praebitores in Sinis. Nostra officina in API, anti-cancro, antivirali medicamento media, subtilia chemicis, cibariis additivis export et plus quam X annos importat, positi sunt, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniae Regnum. Gallia, etc., et paulatim plus XX regionibus circum orbem terrarum tegunt.
View as  
 
5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenosine-3'-(2-cyanoethyl-N, N-diisopropyl) phosphoramidite

5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenosine-3'-(2-cyanoethyl-N, N-diisopropyl) phosphoramidite

Product Name:5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
Formulae hypotheticae: C47H52N7O7P
Molecular pondus:857.93
CAS Subcriptio Number:98796-53-3

Lege plusMitte Inquisitionem
2'-Deoxycytidine hydrochloridis

2'-Deoxycytidine hydrochloridis

Product Name: 2'-Deoxycytidine hydrochloridis
Formulae hypotheticae: C9H14ClN3O4
Molecular pondus:263.68
CAS Subcriptio Number: 3992-42-5

Lege plusMitte Inquisitionem
2'-Deoxyguanosine

2'-Deoxyguanosine

Product Name:2'-Deoxyguanosine
Formulae hypotheticae: C10H13N5O4
Molecular pondus:267.24
CAS Subcriptio Number: 961-07-9

Lege plusMitte Inquisitionem
2'-Deoxyinosine

2'-Deoxyinosine

Product Name: 2'-Deoxyinosine
Formulae hypotheticae: C10H12N4O4
Molecular pondus:252.23
CAS Subcriptio Number:890-38-0

Lege plusMitte Inquisitionem
2'-Deoxyuridine

2'-Deoxyuridine

Product Name:2'-Deoxyuridine
Formulae hypotheticae: C9H12N2O5
Molecular pondus:228.2
CAS Subcriptio Number:951-78-0

Lege plusMitte Inquisitionem
2'-Deoxycytidine monohydratorum

2'-Deoxycytidine monohydratorum

Product Name:2'-Deoxycytidine monohydratorum
Formulae hypotheticae: C9H13N3O4
Molecular pondus:227.22
CAS Subcriptio Number:951-77-9

Lege plusMitte Inquisitionem
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept